Americans’ Use of Dietary Supplements That Are Potentially Harmful in CKD
Supporting Files
-
Feb 14 2013
-
File Language:
English
Details
-
Alternative Title:Am J Kidney Dis
-
Personal Author:
-
Corporate Authors:
-
Description:Background
The prevalence in the United States of dietary supplement use that may be harmful to those with chronic kidney disease (CKD) is unknown. We sought to characterize potentially harmful supplement use by individual CKD status.
Study Design
Cross-sectional national survey (National Health and Nutrition Examination Survey, 1999-2008)
Setting & Participants
Community-based survey of 21,169 non-pregnant, non-institutionalized U.S. civilian adults (≥20 years)
Predictor
CKD status (no CKD, at risk for CKD [presence of diabetes, hypertension and/or cardiovascular disease], stage 1/2 [albuminuria only (albumin-creatinine ratio ≥30 mg/g)], or stage 3/4 [estimated glomerular filtration rate of 15-59 ml/min/1.73 m2]).
Outcome
Self-reported use of dietary supplements containing any of 37 herbs the National Kidney Foundation identified as potentially harmful in the setting of CKD.
Measurements
Albuminuria and estimated glomerular filtration rate assessed from urine and blood samples; demographics and comorbid conditions assessed by standardized questionnaire.
Results
An estimated 8.0% of U.S. adults reported potentially harmful supplement use within the last 30 days. Lower crude estimated prevalence of potentially harmful supplement use was associated with higher CKD severity (no CKD, 8.5%; at risk, 8.0%; stage 1/2, 6.1%; and stage 3/4, 6.2%; p<0.001). However, after adjustment for confounders, those with or at risk for CKD were as likely to use a potentially harmful supplement as those without CKD: at-risk OR, 0.93 (95% CI, 0.79 -1.09); stage 1/2 OR, 0.83 (95% CI, 0.64 -1.08); stage 3/4 OR, 0.87 (95% CI, 0.63 -1.18); all vs. no CKD.
Limitations
Herb content was not available and the list of potentially harmful supplements examined is unlikely to be exhaustive.
Conclusions
The use of dietary supplements potentially harmful to people with CKD is common, regardless of CKD status. Healthcare providers should discuss the use and potential risks of supplements with patients with and at risk for CKD.
-
Subjects:
-
Source:Am J Kidney Dis. 2013; 61(5):739-747.
-
Pubmed ID:23415417
-
Pubmed Central ID:PMC3628413
-
Document Type:
-
Funding:1U58DP003839-01/DP/NCCDPHP CDC HHS/United States ; K23 DK094850/DK/NIDDK NIH HHS/United States ; K24 DK002643/DK/NIDDK NIH HHS/United States ; KL2RR024130/RR/NCRR NIH HHS/United States ; R01 DK70939/DK/NIDDK NIH HHS/United States ; R01 DK78124/DK/NIDDK NIH HHS/United States ; T32 DK007219/DK/NIDDK NIH HHS/United States
-
Place as Subject:
-
Volume:61
-
Issue:5
-
Collection(s):
-
Main Document Checksum:urn:sha256:e934de74a87f9e95bdec52d543d627ae1f76d4d1cd3749636f4267a7a710551c
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access